ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $271,000 | -35.9% | 3,900 | -29.1% | 0.00% | -25.0% |
| Q4 2020 | $423,000 | -18.0% | 5,500 | -20.3% | 0.00% | -33.3% |
| Q3 2020 | $516,000 | -15.5% | 6,900 | -28.9% | 0.01% | -14.3% |
| Q2 2020 | $611,000 | -44.0% | 9,700 | -62.7% | 0.01% | -53.3% |
| Q1 2020 | $1,092,000 | -22.7% | 26,000 | -16.4% | 0.02% | 0.0% |
| Q4 2019 | $1,413,000 | +16.5% | 31,100 | +17.4% | 0.02% | +7.1% |
| Q3 2019 | $1,213,000 | -18.9% | 26,500 | +3.9% | 0.01% | -17.6% |
| Q2 2019 | $1,495,000 | +53.6% | 25,500 | +17.5% | 0.02% | +54.5% |
| Q1 2019 | $973,000 | +9.6% | 21,700 | -4.8% | 0.01% | -8.3% |
| Q4 2018 | $888,000 | -20.3% | 22,800 | -5.8% | 0.01% | -7.7% |
| Q3 2018 | $1,114,000 | -19.9% | 24,200 | -24.1% | 0.01% | -23.5% |
| Q2 2018 | $1,391,000 | +10.4% | 31,900 | 0.0% | 0.02% | +13.3% |
| Q1 2018 | $1,260,000 | – | 31,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |